Ampio announces results from Optina trial on DME Ampio Pharmaceuticals, Inc. The primary endpoint was change from baseline to week twelve of treatment in retinal thickness as measured by Optical Coherence Tomography . Secondary endpoints were 1) differ from baseline to week twelve in retinal quantity and 2) change from baseline to week twelve in Early Treatment Diabetic Retinopathy Study Best Corrected Visual Acuity tadalafil apotek sverige click here .

http://www.cialisisverige.com/

Amlodipine benazepril capsules for treatment of hypertension launched in america market Dr. Reddy’s Laboratories announced today that it launched amlodipine benazepril capsules granted an authorization of Dr. Reddy’s ANDA for amlodipine benazepril on April 15, 2010. Amlodipine benazepril can be indicated for the treatment of hypertension in patients not adequately managed with either agent and is taken once daily. Dr. Reddy’s product comes in bottles of 100 count capsules.